Rare diseases
Investigational molecules
Locations
Back to Bulgaria168 clinical trials in Stara Zagora, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood
BulgariaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
BulgariaStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
BulgariaStudy on ITI-1284 for Treating Agitation in Alzheimer's Patients
BulgariaStudy of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
BulgariaStudy on ITI-1284 for Treating Psychosis in Alzheimer's Patients
BulgariaStudy on the Effectiveness and Safety of Efgartigimod IV for Adults with Primary Immune Thrombocytopenia
BulgariaStudy of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy
BulgariaStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
BulgariaStudy on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants
BulgariaStudy on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria
BulgariaStudy Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on inflammatory disorders are evaluating novel treatments for conditions including psoriatic arthritis and hidradenitis suppurativa. Researchers are testing innovative therapies targeting specific inflammatory pathways.
These studies aim to improve quality of life for patients with chronic inflammatory conditions.
Research in respiratory diseases includes multiple trials investigating new treatments for asthma. Studies are examining both established and experimental medications to enhance breathing function and disease control.
Emphasis is placed on developing treatments for moderate to severe cases.
Groundbreaking research in blood cancers and solid tumors includes studies on acute myeloid leukemia, chronic lymphocytic leukemia, and prostate cancer. Novel therapeutic approaches are being evaluated.
These trials aim to improve survival rates and treatment outcomes.
Studies in neurological disorders are investigating treatments for epilepsy and examining extended-release formulations of existing medications to improve seizure control.
Focus is on developing more effective treatment options for patients with refractory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
